$424.59
Live
Elevance Health Inc is a healthcare company that leverages data analytics and artificial intelligence to improve patient outcomes and reduce healthcare costs.
0.41%
Downside
Day's Volatility :2.6%
Upside
2.2%
6.27%
Downside
52 Weeks Volatility :29.84%
Upside
25.15%
Period | Elevance Health, Inc | Sector (Health Care) | S&P500 |
---|---|---|---|
3 Months | -14.51% | 3.6% | 6.5% |
6 Months | -19.06% | 10.2% | 18.1% |
1 Year | -4.65% | 19.6% | 38.8% |
3 Years | 0.08% | 16.8% | 28.9% |
Market Capitalization | 103.0B |
Book Value | $168.64 |
Dividend Share | 0.0 |
Dividend Yield | 1.31% |
Earnings Per Share (EPS) | 28.58 |
PE Ratio | 15.55 |
PEG Ratio | 0.73 |
Wall Street Target Price | 586.44 |
Profit Margin | 3.9% |
Operating Margin TTM | 6.93% |
Return On Assets TTM | 5.93% |
Return On Equity TTM | 16.58% |
Revenue TTM | 171.7B |
Revenue Per Share TTM | 735.1 |
Quarterly Revenue Growth YOY | -0.1% |
Gross Profit TTM | 40.1B |
EBITDA | 11.4B |
Diluted Eps TTM | 28.58 |
Quarterly Earnings Growth YOY | 0.26 |
EPS Estimate Current Year | 36.67 |
EPS Estimate Next Year | 40.75 |
EPS Estimate Current Quarter | 10.01 |
EPS Estimate Next Quarter | 9.82 |
What analysts predicted
Upside of 38.12%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 92.1B | ↑ 2.29% |
Net Income | 3.8B | ↓ 2.41% |
Net Profit Margin | 4.07% | ↓ 0.2% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 104.2B | ↑ 13.15% |
Net Income | 4.8B | ↑ 28.19% |
Net Profit Margin | 4.61% | ↑ 0.54% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 121.9B | ↑ 16.94% |
Net Income | 4.6B | ↓ 4.89% |
Net Profit Margin | 3.75% | ↓ 0.86% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 138.6B | ↑ 13.76% |
Net Income | 6.2B | ↑ 34.69% |
Net Profit Margin | 4.44% | ↑ 0.69% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 156.6B | ↑ 12.95% |
Net Income | 5.9B | ↓ 4.29% |
Net Profit Margin | 3.76% | ↓ 0.68% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 171.3B | ↑ 9.42% |
Net Income | 6.0B | ↑ 1.58% |
Net Profit Margin | 3.49% | ↓ 0.27% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 42.2B | ↑ 8.15% |
Net Income | 2.0B | ↑ 105.12% |
Net Profit Margin | 4.75% | ↑ 2.24% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 43.7B | ↑ 3.56% |
Net Income | 1.9B | ↓ 7.53% |
Net Profit Margin | 4.24% | ↓ 0.51% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 42.8B | ↓ 1.88% |
Net Income | 1.3B | ↓ 30.44% |
Net Profit Margin | 3.01% | ↓ 1.23% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 42.6B | ↓ 0.47% |
Net Income | 856.0M | ↓ 33.59% |
Net Profit Margin | 2.01% | ↓ 1.0% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 42.6B | ↓ 0.16% |
Net Income | 2.2B | ↑ 162.38% |
Net Profit Margin | 5.28% | ↑ 3.27% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 43.6B | ↑ 2.51% |
Net Income | 2.3B | ↑ 2.4% |
Net Profit Margin | 5.27% | ↓ 0.01% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 71.6B | ↑ 1.46% |
Total Liabilities | 43.0B | ↓ 2.29% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 77.5B | ↑ 8.22% |
Total Liabilities | 45.7B | ↑ 6.26% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 86.6B | ↑ 11.83% |
Total Liabilities | 53.4B | ↑ 16.82% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 97.3B | ↑ 12.34% |
Total Liabilities | 61.2B | ↑ 14.53% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 102.8B | ↑ 5.62% |
Total Liabilities | 66.4B | ↑ 8.5% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 108.9B | ↑ 5.99% |
Total Liabilities | 69.5B | ↑ 4.74% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 109.0B | ↑ 6.1% |
Total Liabilities | 71.6B | ↑ 7.84% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 109.2B | ↑ 0.12% |
Total Liabilities | 70.9B | ↓ 1.01% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 110.5B | ↑ 1.2% |
Total Liabilities | 71.9B | ↑ 1.53% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 108.9B | ↓ 1.4% |
Total Liabilities | 69.5B | ↓ 3.36% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 111.9B | ↑ 2.72% |
Total Liabilities | 71.2B | ↑ 2.39% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 113.0B | ↑ 0.98% |
Total Liabilities | 70.7B | ↓ 0.69% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 3.8B | ↓ 8.55% |
Investing Cash Flow | -1.3B | ↓ 75.23% |
Financing Cash Flow | -2.2B | ↓ 624.95% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 6.1B | ↑ 58.37% |
Investing Cash Flow | -2.8B | ↑ 121.76% |
Financing Cash Flow | -2.3B | ↑ 1.12% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 10.7B | ↑ 76.34% |
Investing Cash Flow | -7.3B | ↑ 162.32% |
Financing Cash Flow | -2.6B | ↑ 13.28% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 8.4B | ↓ 21.74% |
Investing Cash Flow | -9.6B | ↑ 31.59% |
Financing Cash Flow | 423.0M | ↓ 116.48% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 8.4B | ↑ 0.42% |
Investing Cash Flow | -4.6B | ↓ 52.69% |
Financing Cash Flow | -1.3B | ↓ 411.58% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 6.5B | ↓ 526.15% |
Investing Cash Flow | -3.2B | ↓ 30.18% |
Financing Cash Flow | -531.0M | ↑ 105.81% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.0B | ↓ 69.86% |
Investing Cash Flow | -672.0M | ↓ 78.89% |
Financing Cash Flow | -1.4B | ↑ 169.3% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.6B | ↑ 34.0% |
Investing Cash Flow | -4.5B | ↑ 576.04% |
Financing Cash Flow | -994.0M | ↓ 30.49% |
Sell
Neutral
Buy
Elevance Health, Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Elevance Health, Inc | -19.32% | -19.06% | -4.65% | 0.08% | 70.22% |
The Cigna Corp | -5.34% | -4.86% | 11.61% | 55.39% | 101.51% |
Centene Corp. | -17.69% | -17.94% | -12.48% | -10.1% | 35.5% |
Unitedhealth Group Incorporated | -0.66% | 15.96% | 9.21% | 28.79% | 133.52% |
Cvs Health Corporation | 4.81% | -13.34% | -12.54% | -30.53% | -8.16% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Elevance Health, Inc | 15.55 | 15.55 | 0.73 | 36.67 | 0.17 | 0.06 | 0.01 | 168.64 |
The Cigna Corp | 27.89 | 27.89 | 0.78 | 28.5 | 0.09 | 0.03 | 0.02 | 147.88 |
Centene Corp. | 11.68 | 11.68 | 0.59 | 6.82 | 0.11 | 0.04 | NA | 52.0 |
Unitedhealth Group Incorporated | 36.83 | 36.83 | 1.49 | 27.62 | 0.15 | 0.07 | 0.01 | 107.4 |
Cvs Health Corporation | 11.33 | 11.33 | 2.09 | 6.53 | 0.1 | 0.03 | 0.04 | 59.66 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Elevance Health, Inc | Buy | $103.0B | 70.22% | 15.55 | 3.9% |
The Cigna Corp | Buy | $98.7B | 101.51% | 27.89 | 1.72% |
Centene Corp. | Buy | $32.6B | 35.5% | 11.68 | 1.96% |
Unitedhealth Group Incorporated | Buy | $522.7B | 133.52% | 36.83 | 3.64% |
Cvs Health Corporation | Buy | $80.1B | -8.16% | 11.33 | 1.99% |
Insights on Elevance Health, Inc
Revenue is up for the last 2 quarters, 42.57B → 43.64B (in $), with an average increase of 2.5% per quarter
Netprofit is up for the last 3 quarters, 856.0M → 2.3B (in $), with an average increase of 32.1% per quarter
In the last 1 year, The Cigna Corp has given 9.5% return, outperforming this stock by 14.6%
In the last 3 years, The Cigna Corp has given 55.4% return, outperforming this stock by 55.3%
Vanguard Group Inc
BlackRock Inc
T. Rowe Price Associates, Inc.
State Street Corp
Geode Capital Management, LLC
FMR Inc
In the quarter ending March,2024. Elevance Health, Inc has declared dividend of $1.63
Read MoreElevance Health, Inc. is an American health insurance provider. Prior to June 2022, Elevance Health was named Anthem, Inc.
Organization | Elevance Health, Inc |
Employees | 104900 |
CEO | Ms. Gail Koziara Boudreaux |
Industry | Healthcare |
Tenet Healthcare Corp.
$424.59
-1.43%
Biogen Inc.
$424.59
-1.43%
Zimmer Biomet Holdings, Inc.
$424.59
-1.43%
Edwards Lifesciences Corp.
$424.59
-1.43%
United Therapeutics Corporation
$424.59
-1.43%
Iqvia Holdings Inc.
$424.59
-1.43%
Molina Healthcare, Inc.
$424.59
-1.43%
Fresenius Medical Care Ag
$424.59
-1.43%
Biomarin Pharmaceutical Inc.
$424.59
-1.43%